U.S. biotech firm Arcturus Therapeutics said it expects to start distributing its COVID-19 vaccine candidate in the first quarter of next year after early stage trials showed promising results. The firm said in a statement late on Monday it had already struck multi-million dollar supply deals with Israel and Southeast Asian city-state Singapore, where it is working on the vaccine with a local university and has been conducting trials. Arcturus said its ARCT-021 vaccine candidate has been generally well tolerated in trials so far, with the majority of adverse events being mild.
Hence then, the article about arcturus expects its covid 19 vaccine to be ready by first quarter 2021 was published today ( ) and is available onYahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Arcturus expects its COVID-19 vaccine to be ready by first-quarter 2021 )